Journals / ANKEM Dergisi / 2007 / Cilt: 21 - Sayı: 2

Antibiotic resistance of citrobacter strains ısolated between 2004 and 2006

2004-2006 yılları arasında izole edilen citrobacter suşlarında antibiyotik direnci

Pages
91–94
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

It is determined that the most efficient antibiotics are meropenem and amikacin, followed by levofloxacin, ciprofloxacin and gentamicin, respectively.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:The aim of this study is to detect the antibiotic resistance of Citrobacter strains isolated from clinical specimens between January 2004 and December 2006 as infection agents. 53 C.freundii, 9 C. braakii, 3 C.koseri and 8 C.youngae, totally 73 Citrobacter strains were isolated.
📊
Key Findings & Data:When MIC values of isolates were taken into consideration altogether, rates of resistance were as follows; 85 % to ampicillin, 63 % to piperacillin-tazobactam, 47 % to cefoxitin, 84 % to cefoxitin, 48 % to ceftazidime, 45 % to cefepime, 7 % to amikacin, 38 % to gentamicin, 55 % to aztreonam, 1 % to meropenem, 37 % to ciprofloxacin, 30 % to levofloxacin and 48 % to cotrimoxazole.
💡
Conclusion & Impact:It is determined that the most efficient antibiotics are meropenem and amikacin, followed by levofloxacin, ciprofloxacin and gentamicin, respectively.
🔬Design:Research Article
📍Scope:2004 Verileri
⚙️Variables:Domain Parameters

Abstract

The aim of this study is to detect the antibiotic resistance of Citrobacter strains isolated from clinical specimens between January 2004 and December 2006 as infection agents. 53 C.freundii, 9 C. braakii, 3 C.koseri and 8 C.youngae, totally 73 Citrobacter strains were isolated. When MIC values of isolates were taken into consideration altogether, rates of resistance were as follows; 85 % to ampicillin, 63 % to piperacillin-tazobactam, 47 % to cefoxitin, 84 % to cefoxitin, 48 % to ceftazidime, 45 % to cefepime, 7 % to amikacin, 38 % to gentamicin, 55 % to aztreonam, 1 % to meropenem, 37 % to ciprofloxacin, 30 % to levofloxacin and 48 % to cotrimoxazole. It is determined that the most efficient antibiotics are meropenem and amikacin, followed by levofloxacin, ciprofloxacin and gentamicin, respectively.

Özet

Ocak 2004-Aralık 2006 tarihleri arasında infeksiyon etkeni olarak izole edilen Citrobacter suşlarının antibiyotik dirençlerinin belirlenmesi amaçlanmıştır. 73 Citrobacter suşundan 53’ü C.freundii, 9’u C.braakii, 3’ü C.koseri, 8’i C.youngae olarak identifiye edilmiştir. İzole edilen suşların toplamında MİK değerlerine göre direnç oranlarına bakıldığında ampisiline % 85, piperasiline % 63, piperasilin-tazobaktama % 47, sefoksitine % 84, seftazidime % 48, sefepime % 45, amikasine % 7, gentamisine % 38, aztreonama % 55, meropeneme % 1, siprofloksasine % 37, levofloksasine % 30 ve ko-trimoksazole % 48 oranlarında direnç saptanmıştır. Meropenem ve amikasin en etkili antibiyotikler olarak bulunmuş, bunları levo-floksasin, siprofloksasin ve gentamisin izlemiştir.

🔖

Cite This Article

GÜLHAN, B., ÖZEKİNCİ, T., MEŞE, S., ATMACA, S. (2007). Antibiotic resistance of citrobacter strains ısolated between 2004 and 2006. ANKEM Dergisi, Cilt: 21 - Sayı: 2, 91–94. https://ajindex.com/articles/198055

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (6)

  1. Abbott SL: Klebsiella, Enterobacter, Citrobacter, Serratia, Plesiomonas, and other Enterobacteriaceae,“Murray PR, Baron EJ, Pfaller MA, Jorgensen JH, Yolken RH (eds): Manual of Clinical Microbiology,8. baskı” kitabında s. 684-95, ASM Press, Washington, DC (2003)
  2. Abu Setteh MH: Uropathogens and their susceptibility patterns at King Hussein Medical Center-Jordan, Gülhane Tıp Derg 2004;46(1):10-4
  3. Akalın H: Enterobacter ve diğer Gram negatif enterikler,“Topçu AW, Söyletir G, Doğanay M: infeksiyon Hastalıkları ve Mikrobiyolojisi, 2.ci baskı” kitabında s. 1583-4, Nobel Tıp Kitabevleri, İstanbul (2002)
  4. Durmaz B, Özerol İH, Şahin K, Tekerekoğlu MS,Köroğlu M: Enterobacteriaceae üyesi ve Pseudomonas cinsi bakterilerin b-laktam antibiyotiklere direnci, Turgut Özal Tıp Merkezi Derg 1997;4(2):193-6 5. Mohanty S, Singhal R, Sood S, Dhawan B, Kapil A, Das BK: Citrobacter infections in a tertiary care hospital in Northern India, J Infect 2007;54(1):58-64
  5. National Committee for Clinical Laboratory Standards:Approved Standard M7-A6, Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically, 6th ed., NCCLS,Wayne, PA (2003)
  6. Rice LB, Sahm D, Bonomo RA: Mechanisms of resistance to antibacterial agents, “Murray PR, Baron EJ, Pfaller MA, Jorgensen JH, Yolken RH (eds): Manual of Clinical Microbiology, 8. baskı”kitabında s. 1086, ASM Press, Washington, DC (2003).